Hannah Beier/Bloomberg via Getty Images(NEW YORK) -- Novavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults that can be used on top of the its primary vaccine series or to mix and match with a different primary series, the company

Related Keywords

Boston , Massachusetts , United States , Americans , American , Stanleyc Erck , Hannah Beier Bloomberg , Johnson , John Brownstein , Centers For Disease , Pfizer , Drug Administration For Emergency Use Authorization , Drug Administration , Emergency Use Authorization , Chief Executive Officer , Disease Control , Boston Children ,